VRIDAPA TM 10/20/500 TABLET
Generic Salt Composition: Dapagliflozin 10mg + Teneligliptin 20mg + Metformin 500mg SR
Price: ₹62 MRP: ₹121.8
Save up to 49% compared to branded medicines.
Top Brand Substitutes & Equivalents
Dapa-Tene-Met, Teneligliptin-Dapagliflozin-Metformin, Dapa-Tene-M, Tene-Dapa-Met, Gluco-Triple, Dapa-Tene-Met SR, Tene-Dapa-Metformin, Dapa-Tene-M 500, Tene-Dapa-M, Dapa-Tene-Met 10/20/500, Tene-Dapa-Met 10/20/500, Dapa-Tene-Met Tablet, Tene-Dapa-Met Tablet, Dapa-Tene-Met SR Tablet, Glycomet 500 SR, Glycomet 850, Glycomet 1000 SR, Cetapin 500, Cetapin 1000, Glucophage 500, Glucophage XR 1000, Obimet 500, Obimet 1000, Formin 500, Exermet 500, Metfor 500, Glycomet GP 1, Glycomet GP 2, Gluconorm-G 1, Gluconorm-G 2
Product Overview & Uses
VRIDAPA TM 10/20/500 TABLET is a comprehensive oral antihyperglycemic agent designed for the management of Type 2 Diabetes Mellitus. Within the Diabetes Care category, this medication provides a multi-faceted approach to glucose regulation. Dapagliflozin works by preventing the kidneys from reabsorbing glucose, allowing it to be excreted in the urine. Teneligliptin enhances insulin secretion and suppresses glucagon release by inhibiting the DPP-4 enzyme. Metformin, the cornerstone of diabetes treatment, reduces hepatic glucose production and improves insulin sensitivity. By combining these three distinct mechanisms, VRIDAPA TM 10/20/500 TABLET offers robust glycemic control, helping patients achieve their HbA1c targets while minimizing the risk of hypoglycemia often associated with other classes of antidiabetic drugs.